Trials that use: Odds ratio
New to this method? Read the tutorial →
5,976 results
- Single Dose PK of IV Tedizolid Phosphate in Morbidly Obese and Non-Obese Adults: Complete Statistical AnalysisIndependent statistical analysis of Single Dose PK of IV Tedizolid Phosphate in Morbidly Obese and Non-Obese Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Complete Statistical AnalysisIndependent statistical analysis of Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections: primary endpoint results, effect estimate with confidence interval, sample-size…
- Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027): Complete Statistical AnalysisIndependent statistical analysis of Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01106287).
- Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Single or Double-layer Uterine Closure Techniques: Complete Statistical AnalysisIndependent statistical analysis of Single or Double-layer Uterine Closure Techniques: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03629028).
- Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects: Complete Statistical AnalysisIndependent statistical analysis of Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SIPIIndependent statistical analysis of Satisfaction of Limited English-Proficient Patients With Phone Interpretation Services Compared to In-Person Interpreters: A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- sipITIndependent statistical analysis of Feasibility of Using sipIT Tools to Increase Compliance With Fluid Consumption Guidelines in Urolithiasis-Prone Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SirolimusIndependent statistical analysis of Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sirolimus for Autoimmune Disease of Blood Cells: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus for Autoimmune Disease of Blood Cells: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00392951).
- Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02357342).
- SISCAIndependent statistical analysis of Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SISTErIndependent statistical analysis of Comparison of Surgical Procedures to Reduce Urinary Stress Incontinence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00064662).
- Sitagliptin Therapy to Improve Outcomes After Islet Autotransplant: Complete Statistical AnalysisIndependent statistical analysis of Sitagliptin Therapy to Improve Outcomes After Islet Autotransplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01186562).
- Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182): Complete Statistical AnalysisIndependent statistical analysis of Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01065766).
- Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS): Complete Statistical AnalysisIndependent statistical analysis of Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas: Complete Statistical AnalysisIndependent statistical analysis of Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02978859).
- SiyakhanaIndependent statistical analysis of Community Health Worker Training to Reduce Depression and Substance Use Stigma in TB/HIV Care in South Africa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women: Complete Statistical AnalysisIndependent statistical analysis of SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients: Complete Statistical AnalysisIndependent statistical analysis of SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SKYGGNIndependent statistical analysis of OCS-01 in Treating Inflammation and Pain in Post-cataract Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04130802).
- SLAM-PDIndependent statistical analysis of Speech, Linguistic and Acoustic Markers in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04273672).
- SLD3Independent statistical analysis of Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SLEIndependent statistical analysis of A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01689350).
- Sleep Innovations for Preschoolers With Arthritis (SIPA): Developing and Pilot Testing of a Self-Management Intervention: Complete Statistical AnalysisIndependent statistical analysis of Sleep Innovations for Preschoolers With Arthritis (SIPA): Developing and Pilot Testing of a Self-Management Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sleepiness and the Effects of CPAP on Salivary Cortisol and Alpha-Amylase Levels in Patients With Sleep Apnea: Complete Statistical AnalysisIndependent statistical analysis of Sleepiness and the Effects of CPAP on Salivary Cortisol and Alpha-Amylase Levels in Patients With Sleep Apnea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SLIMM-T2DIndependent statistical analysis of Surgery or Lifestyle With Intensive Medical Management in the Treatment of Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SMA002Independent statistical analysis of A Clinical Study of the Performance of a Glucose Blinding Protein-Based Continuous Glucose Monitor (GBP CGM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Smart Telehealth Exercise Intervention to Reduce COPD Readmissions: Complete Statistical AnalysisIndependent statistical analysis of Smart Telehealth Exercise Intervention to Reduce COPD Readmissions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03089853).
- Smart-TR01Independent statistical analysis of Smartphone Based Smoking Cessation Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03740490).
- SmartfIREIndependent statistical analysis of A Study For Treatment Of Paroxysmal Atrial Fibrillation (PAF) With The THERMOCOOL SMARTTOUCH SF Catheter and TRUPULSE Generator: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SMARTPLUS-106Independent statistical analysis of Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Smoke-free Home Intervention in Permanent Supportive Housing: Complete Statistical AnalysisIndependent statistical analysis of Smoke-free Home Intervention in Permanent Supportive Housing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04855357).
- Smoking Cessation for Smokers With Sleep Problems: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation for Smokers With Sleep Problems: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01277887).
- Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Smoking Cessation Intervention for Thoracic Patients: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation Intervention for Thoracic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00580398).
- Smoking Cessation Intervention in Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation Intervention in Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03024606).
- Smoking Cessation Interventions for People Living With HIV in Nairobi, Kenya: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation Interventions for People Living With HIV in Nairobi, Kenya: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SMS TurkeyIndependent statistical analysis of SMS Turkey: Harnessing the Power of Text Messaging to Promote Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SMV + SOF With/Without RBV for IFN-II Patients With CHC: Complete Statistical AnalysisIndependent statistical analysis of SMV + SOF With/Without RBV for IFN-II Patients With CHC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02214420).
- SNIFFLE-3Independent statistical analysis of Efficacy & Safety of Nasal Influenza Immunisation in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02549365).
- SOCIALIndependent statistical analysis of Supporting Our Caregivers In ADRD Learning (SOCIAL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06276023).
- SOCRIndependent statistical analysis of Sensor Optimization of Cardiac Resynchronization Therapy Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01832493).
- SOCRATESIndependent statistical analysis of the SOCRATES phase 3 trial of ticagrelor versus acetylsalicylic acid after acute ischaemic stroke or transient ischaemic attack, including endpoint definitions, Cox and logistic regression methods, efficacy results,…
- SOCRATESIndependent statistical analysis of [SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical Tumors: Complete Statistical AnalysisIndependent statistical analysis of Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03752203).
- Sodium Nitroprusside in Early Course Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Sodium Nitroprusside in Early Course Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04986072).
- Sodium Risedronate Tablets – Special Drug Use Surveillance in Patients With Osseous Paget’s Disease (All-case Surveillance) -48-week Surveillance -: Complete Statistical AnalysisIndependent statistical analysis of Sodium Risedronate Tablets - Special Drug Use Surveillance in Patients With Osseous Paget's Disease (All-case Surveillance) -48-week Surveillance -: primary endpoint results, effect estimate with confidence interval, sample-size…